Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2019-08-20 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Resultat for 2 kvartal og første halvår 2019 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the second quarter and first half of 2019. It contains detailed financial statements, including revenue, EBIT, balance sheet data, operational status by region, and management commentary from the CEO. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q2 2019
2019-08-20 Norwegian
Results for second quarter and first half of 2019 for Medistim ASA
Earnings Release Classification · 99% confidence The document explicitly states it is the "2nd quarter and 1st half report for 2019". It contains detailed financial performance metrics (Sales, EBIT, Profit, Balance Sheet, Cost of Goods Sold) for both the quarter and the first half of the year, along with commentary from the CEO and operational reviews by segment. This structure and content strongly indicate a comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not an Annual Report (10-K) because it covers only the first half of the year, nor is it a brief Earnings Release (ER) as it contains extensive operational and balance sheet details. Q2 2019
2019-08-20 English
Resultat for 2 kvartal og første halvår 2019 for Medistim ASA
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Second quarter 2019" and contains detailed financial statements for Q2 2019 and Year-to-Date June 2019, including Profit and Loss statements, Balance Sheets, and segment revenue breakdowns. It also includes operational highlights and strategic updates. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year (a quarter). Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not a brief announcement (RPA/ER) but the detailed report itself.
2019-08-20 Norwegian
Results for second quarter and first half of 2019 for Medistim ASA
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Second quarter 2019" and contains detailed financial statements for Q2 2019 and Year-to-Date June 2019, including Profit and Loss statements, Balance Sheets, and segment revenue breakdowns. It also includes operational highlights and strategic updates. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year (a quarter). Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not a brief announcement (RPA/ER) but the detailed report itself.
2019-08-20 English
Resultat for 2 kvartal og første halvår 2019 for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly states 'Resultat for 2 kvartal og første halvår 2019' (Results for the 2nd quarter and first half of 2019) and provides key financial metrics like revenue (Omsetningen), operating result (Driftsresultatet/EBIT), and growth percentages for the period. This content structure, focusing on summarized financial performance for a specific interim period (half-year/quarter), aligns perfectly with the definition of an Interim/Quarterly Report (IR). It is not a full Annual Report (10-K) because it covers only the first half of the year, nor is it just an Earnings Release (ER) as it provides detailed segment/geographic performance (USA growth) and EBIT figures, suggesting a more comprehensive summary than a typical ER press release. H1 2019
2019-08-20 Norwegian Nynorsk
Results for second quarter and first half of 2019 for Medistim ASA
Earnings Release Classification · 100% confidence The document explicitly states it contains 'Results for second quarter and first half of 2019' and provides key financial metrics like Sales, Operating Profit (EBIT), and dividend information for these periods. This content structure is characteristic of an initial announcement of periodic financial results, which aligns with the Earnings Release (ER) definition. It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather a summary of key figures, making ER the most appropriate classification. The document length is short, but it contains the core results, not just an announcement that results are forthcoming. H1 2019
2019-08-20 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.